• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

50岁及以上澳大利亚人的流感相关住院和死亡情况。

Influenza-related hospitalisation and death in Australians aged 50 years and older.

作者信息

Newall Anthony T, Wood James G, Macintyre C Raina

机构信息

The School of Public Health, The University of Sydney, NSW, Australia.

出版信息

Vaccine. 2008 Apr 16;26(17):2135-41. doi: 10.1016/j.vaccine.2008.01.051. Epub 2008 Feb 15.

DOI:10.1016/j.vaccine.2008.01.051
PMID:18325639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7125633/
Abstract

Estimating the true burden of influenza is problematic because relatively few hospitalisations or deaths are specifically coded as influenza related. Statistical regression techniques using influenza and respiratory syncytial virus surveillance data were used to estimate the number of excess hospitalisations and deaths attributable to influenza. Several International Classification of Diseases 10th Revision (ICD-10) groupings were used for both hospitalisation and mortality estimates, including influenza and pneumonia, other respiratory disorders, and circulatory disorders. For Australians aged 50-64 years, the annual excess hospitalisations attributable to influenza were 33.3 (95%CI: 23.2-43.4) per 100,000 for influenza and pneumonia and 57.6 (95%CI: 32.5-82.8) per 100,000 for other respiratory disorders. For Australians aged > or =65 years, the annual excess hospitalisations attributable to influenza were 157.4 (95%CI: 108.4-206.5) per 100,000 for influenza and pneumonia and 282.0 (95%CI: 183.7-380.3) per 100,000 for other respiratory disorders. The annual excess all-cause mortality attributable to influenza was 6.4 (95%CI: 2.6-10.2) per 100,000 and 116.4 (95%CI: 71.3-161.5) per 100,000, for Australians aged 50-64 years and those aged > or =65 years, respectively. In the age-group > or =65 years, a significant association was found between influenza activity and circulatory mortality. We conclude that influenza is responsible for a substantial amount of mortality and morbidity, over and above that which is directly diagnosed as influenza in Australians aged > or =50 years.

摘要

估算流感的真实负担存在问题,因为相对较少的住院或死亡病例被明确编码为与流感相关。利用流感和呼吸道合胞病毒监测数据的统计回归技术,来估算可归因于流感的额外住院和死亡人数。住院和死亡率估算均使用了国际疾病分类第十版(ICD - 10)的几个分组,包括流感和肺炎、其他呼吸系统疾病以及循环系统疾病。对于50 - 64岁的澳大利亚人,每10万人中,因流感和肺炎导致的年度额外住院人数为33.3(95%置信区间:23.2 - 43.4),因其他呼吸系统疾病导致的为57.6(95%置信区间:32.5 - 82.8)。对于65岁及以上的澳大利亚人,每10万人中,因流感和肺炎导致的年度额外住院人数为157.4(95%置信区间:108.4 - 206.5),因其他呼吸系统疾病导致的为282.0(95%置信区间:183.7 - 380.3)。对于50 - 64岁和65岁及以上的澳大利亚人,每10万人中,因流感导致的年度额外全因死亡率分别为6.4(95%置信区间:2.6 - 10.2)和116.4(95%置信区间:71.3 - 161.5)。在65岁及以上年龄组中,发现流感活动与循环系统死亡率之间存在显著关联。我们得出结论,在50岁及以上的澳大利亚人中,流感导致了大量的死亡率和发病率,远超直接诊断为流感的病例数。

相似文献

1
Influenza-related hospitalisation and death in Australians aged 50 years and older.50岁及以上澳大利亚人的流感相关住院和死亡情况。
Vaccine. 2008 Apr 16;26(17):2135-41. doi: 10.1016/j.vaccine.2008.01.051. Epub 2008 Feb 15.
2
Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009-2017.基于模型的 2009-2017 年澳大利亚呼吸道合胞病毒和流感相关住院人数的估计。
Influenza Other Respir Viruses. 2022 Nov;16(6):1082-1090. doi: 10.1111/irv.13003. Epub 2022 Jun 30.
3
Estimated hospitalisations attributable to seasonal and pandemic influenza in Australia: 2001- 2013.澳大利亚季节性和大流行性流感所致住院治疗的估计数:2001-2013 年。
PLoS One. 2020 Apr 13;15(4):e0230705. doi: 10.1371/journal.pone.0230705. eCollection 2020.
4
Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom.英国特定年龄组流感相关住院率和死亡率的建模估计
BMC Public Health. 2016 Jun 8;16:481. doi: 10.1186/s12889-016-3128-4.
5
Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches.50 岁以上澳大利亚人因流感导致的死亡率:不同建模方法的比较。
Epidemiol Infect. 2010 Jun;138(6):836-42. doi: 10.1017/S095026880999118X. Epub 2009 Nov 27.
6
Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013.利用健康与人口监测系统数据估算2007 - 2013年肯尼亚西部流感和呼吸道合胞病毒相关死亡率
PLoS One. 2017 Jul 7;12(7):e0180890. doi: 10.1371/journal.pone.0180890. eCollection 2017.
7
Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009.1998 - 2009年南非高艾滋病毒流行地区5岁以下儿童中与季节性流感、大流行性流感及呼吸道合胞病毒相关的死亡率
Clin Infect Dis. 2014 May;58(9):1241-9. doi: 10.1093/cid/ciu095. Epub 2014 Feb 23.
8
Influenza- and respiratory syncytial virus-associated mortality and hospitalisations.流感和呼吸道合胞病毒相关的死亡率及住院率。
Eur Respir J. 2007 Dec;30(6):1158-66. doi: 10.1183/09031936.00034407. Epub 2007 Aug 22.
9
Estimating the contribution of influenza to hospitalisations in New Zealand from 1994 to 2008.估算1994年至2008年流感对新西兰住院病例的影响。
Vaccine. 2015 Aug 7;33(33):4087-92. doi: 10.1016/j.vaccine.2015.06.080. Epub 2015 Jul 2.
10
Modelling the influenza disease burden in people aged 50-64 and ≥65 years in Australia.在澳大利亚,50-64 岁和≥65 岁人群中流感疾病负担的建模。
Influenza Other Respir Viruses. 2022 Jan;16(1):132-141. doi: 10.1111/irv.12902. Epub 2021 Sep 29.

引用本文的文献

1
Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia.澳大利亚使用高剂量流感疫苗对老年人呼吸道及循环系统加呼吸道住院情况的健康和经济影响估计
Vaccine X. 2023 Aug 4;15:100365. doi: 10.1016/j.jvacx.2023.100365. eCollection 2023 Dec.
2
Influenza presentations and use of neuraminidase inhibitors by Australian general practice registrars: a cross-sectional analysis from the ReCEnT study.澳大利亚全科住院医师中流感的表现和使用神经氨酸酶抑制剂的情况:ReCEnT 研究的横断面分析。
Fam Med Community Health. 2023 Jun;11(2). doi: 10.1136/fmch-2022-002107.
3

本文引用的文献

1
Methods for current statistical analysis of excess pneumonia-influenza deaths.当前过量肺炎-流感死亡统计分析方法。
Public Health Rep (1896). 1963 Jun;78(6):494-506.
2
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.50至64岁人群流感疫苗接种的成本效益:一项国际模型研究
Value Health. 2007 Mar-Apr;10(2):98-116. doi: 10.1111/j.1524-4733.2006.00157.x.
3
Assessing the burden of influenza and other respiratory infections in England and Wales.评估英格兰和威尔士的流感及其他呼吸道感染负担。
Factors of influenza vaccine inoculation and non-inoculation behavior of community-dwelling residents in Japan: Suggestions for vaccine policy and public health ethics after COVID-19.
日本社区居民流感疫苗接种与未接种行为的影响因素:新冠疫情后对疫苗政策及公共卫生伦理的建议
Vaccine X. 2023 Apr;13:100245. doi: 10.1016/j.jvacx.2022.100245. Epub 2022 Dec 13.
4
Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009-2017.基于模型的 2009-2017 年澳大利亚呼吸道合胞病毒和流感相关住院人数的估计。
Influenza Other Respir Viruses. 2022 Nov;16(6):1082-1090. doi: 10.1111/irv.13003. Epub 2022 Jun 30.
5
Modelling the influenza disease burden in people aged 50-64 and ≥65 years in Australia.在澳大利亚,50-64 岁和≥65 岁人群中流感疾病负担的建模。
Influenza Other Respir Viruses. 2022 Jan;16(1):132-141. doi: 10.1111/irv.12902. Epub 2021 Sep 29.
6
Impact of seasonal influenza on polyclinic attendances for upper respiratory tract infections in Singapore.季节性流感对新加坡上呼吸道感染患者就诊人数的影响。
Western Pac Surveill Response J. 2020 Jun 30;11(2):27-36. doi: 10.5365/wpsar.2019.10.4.001. eCollection 2020 Apr-Jun.
7
Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders Network.中东、北非、东非和南非流感监测:第 8 次中东和北非流感利益攸关方网络报告。
Influenza Other Respir Viruses. 2019 May;13(3):298-304. doi: 10.1111/irv.12628. Epub 2019 Feb 22.
8
Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.流感疫苗在老年人、儿童和孕妇群体中的负担、有效性及安全性。
Ther Adv Vaccines Immunother. 2019 Feb 7;7:2515135519826481. doi: 10.1177/2515135519826481. eCollection 2019.
9
Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission.实体器官移植中的传染病传播:供体评估、受体风险及传播结果
Transplant Direct. 2018 Dec 20;5(1):e416. doi: 10.1097/TXD.0000000000000852. eCollection 2019 Jan.
10
Immune regulation of the unfolded protein response at the mucosal barrier in viral infection.病毒感染时黏膜屏障处未折叠蛋白反应的免疫调节
Clin Transl Immunology. 2018 Apr 3;7(4):e1014. doi: 10.1002/cti2.1014. eCollection 2018.
J Infect. 2007 Jun;54(6):530-8. doi: 10.1016/j.jinf.2006.09.017. Epub 2006 Nov 9.
4
Annual report of the National Influenza Surveillance Scheme, 2005.2005年国家流感监测计划年度报告
Commun Dis Intell Q Rep. 2006;30(2):189-200. doi: 10.33321/cdi.2006.30.14.
5
Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.50至64岁及65岁及以上成年人流感疫苗接种的健康影响和成本效益
Am J Prev Med. 2006 Jul;31(1):72-9. doi: 10.1016/j.amepre.2006.03.008.
6
Influenza-related deaths and hospitalizations in Hong Kong: a subtropical area.香港的流感相关死亡及住院情况:一个亚热带地区
Public Health. 2006 Jun;120(6):517-24. doi: 10.1016/j.puhe.2006.03.004. Epub 2006 May 19.
7
Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data.美国流感所致死亡率——一种使用多死因死亡率数据的年化回归方法
Am J Epidemiol. 2006 Jan 15;163(2):181-7. doi: 10.1093/aje/kwj024. Epub 2005 Nov 30.
8
The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.50至64岁健康成年人接种流感疫苗的成本效益。
Vaccine. 2006 Feb 13;24(7):1035-43. doi: 10.1016/j.vaccine.2004.12.033. Epub 2005 Sep 6.
9
Mortality in children from influenza and respiratory syncytial virus.流感和呼吸道合胞病毒导致的儿童死亡率。
J Epidemiol Community Health. 2005 Jul;59(7):586-90. doi: 10.1136/jech.2004.026450.
10
Influenza and its relationship to circulatory disorders.流感及其与循环系统疾病的关系。
Epidemiol Infect. 2005 Apr;133(2):255-62. doi: 10.1017/s0950268804003231.